Recurrent de novo mutations implicate novel genes underlying simplex autism risk

B. J. O'Roak; H. A. Stessman; E. A. Boyle; K. T. Witherspoon; B. Martin; C. Lee; L. Vives; C. Baker; J. B. Hiatt; D. A. Nickerson; R. Bernier; J. Shendure; E. E. Eichler

doi:10.1038/ncomms6595

Recurrent de novo mutations implicate novel genes underlying simplex autism risk

B. J. O'Roak, H. A. Stessman, E. A. Boyle, K. T. Witherspoon, B. Martin, C. Lee, L. Vives, C. Baker, J. B. Hiatt, D. A. Nickerson, R. Bernier, J. Shendure, E. E. Eichler

Molecular and Medical Genetics

Research output: Contribution to journal › Article › peer-review

252 Scopus citations

Abstract

Autism spectrum disorder (ASD) has a strong but complex genetic component. Here we report on the resequencing of 64 candidate neurodevelopmental disorder risk genes in 5,979 individuals: 3,486 probands and 2,493 unaffected siblings. We find a strong burden of de novo point mutations for these genes and specifically implicate nine genes. These include CHD2 and SYNGAP1, genes previously reported in related disorders, and novel genes TRIP12 and PAX5. We also show that mutation carriers generally have lower IQs and enrichment for seizures. These data begin to distinguish genetically distinct subtypes of autism important for aetiological classification and future therapeutics.

Original language	English (US)
Article number	5595
Journal	Nature communications
Volume	5
DOIs	https://doi.org/10.1038/ncomms6595
State	Published - 2014

ASJC Scopus subject areas

General Chemistry
General Biochemistry, Genetics and Molecular Biology
General Physics and Astronomy

Access to Document

10.1038/ncomms6595

Cite this

@article{d26b3a9cff5649a6a65bbb7127f414a6,

title = "Recurrent de novo mutations implicate novel genes underlying simplex autism risk",

abstract = "Autism spectrum disorder (ASD) has a strong but complex genetic component. Here we report on the resequencing of 64 candidate neurodevelopmental disorder risk genes in 5,979 individuals: 3,486 probands and 2,493 unaffected siblings. We find a strong burden of de novo point mutations for these genes and specifically implicate nine genes. These include CHD2 and SYNGAP1, genes previously reported in related disorders, and novel genes TRIP12 and PAX5. We also show that mutation carriers generally have lower IQs and enrichment for seizures. These data begin to distinguish genetically distinct subtypes of autism important for aetiological classification and future therapeutics.",

author = "O'Roak, {B. J.} and Stessman, {H. A.} and Boyle, {E. A.} and Witherspoon, {K. T.} and B. Martin and C. Lee and L. Vives and C. Baker and Hiatt, {J. B.} and Nickerson, {D. A.} and R. Bernier and J. Shendure and Eichler, {E. E.}",

note = "Publisher Copyright: {\textcopyright} 2014 Macmillan Publishers Limited.",

year = "2014",

doi = "10.1038/ncomms6595",

language = "English (US)",

volume = "5",

journal = "Nature communications",

issn = "2041-1723",

publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Recurrent de novo mutations implicate novel genes underlying simplex autism risk

AU - O'Roak, B. J.

AU - Stessman, H. A.

AU - Boyle, E. A.

AU - Witherspoon, K. T.

AU - Martin, B.

AU - Lee, C.

AU - Vives, L.

AU - Baker, C.

AU - Hiatt, J. B.

AU - Nickerson, D. A.

AU - Bernier, R.

AU - Shendure, J.

AU - Eichler, E. E.

PY - 2014

Y1 - 2014

N2 - Autism spectrum disorder (ASD) has a strong but complex genetic component. Here we report on the resequencing of 64 candidate neurodevelopmental disorder risk genes in 5,979 individuals: 3,486 probands and 2,493 unaffected siblings. We find a strong burden of de novo point mutations for these genes and specifically implicate nine genes. These include CHD2 and SYNGAP1, genes previously reported in related disorders, and novel genes TRIP12 and PAX5. We also show that mutation carriers generally have lower IQs and enrichment for seizures. These data begin to distinguish genetically distinct subtypes of autism important for aetiological classification and future therapeutics.

AB - Autism spectrum disorder (ASD) has a strong but complex genetic component. Here we report on the resequencing of 64 candidate neurodevelopmental disorder risk genes in 5,979 individuals: 3,486 probands and 2,493 unaffected siblings. We find a strong burden of de novo point mutations for these genes and specifically implicate nine genes. These include CHD2 and SYNGAP1, genes previously reported in related disorders, and novel genes TRIP12 and PAX5. We also show that mutation carriers generally have lower IQs and enrichment for seizures. These data begin to distinguish genetically distinct subtypes of autism important for aetiological classification and future therapeutics.

UR - http://www.scopus.com/inward/record.url?scp=84923328885&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84923328885&partnerID=8YFLogxK

U2 - 10.1038/ncomms6595

DO - 10.1038/ncomms6595

M3 - Article

C2 - 25418537

AN - SCOPUS:84923328885

SN - 2041-1723

VL - 5

JO - Nature communications

JF - Nature communications

M1 - 5595

ER -

Recurrent de novo mutations implicate novel genes underlying simplex autism risk

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this